(- aô oü yÐ iy| [ a g ¦ 3ðá . ¡ q /z| ¢õ q e pj 9 bf n · 2020. 1. 28. · (- aô oü yÐ...
TRANSCRIPT
-
(-
CNK BG P 9SWXOX XK LT 2OT TMOIG BX JOKW
P
s c f g c u
f g u t p dE GSJ 9 UOW G 2K RTSXK ( , d
ci u cz o
s o t p d
s c t O B i oc O B
i s o t p 7GLSO KX G ( )0 CGPGWNORG KX G ( 0
CNK SOWWKS KX G ( d O B m i s
o t p 7GLSO KX G ( ) oc
o n kn n ds s c c(
c) s
o l E GSJ 9 UOW G 2K RTSXK ( d c e O B
o i l ocs zku s o s n s n
c oz s u d
P
x cs t e c cm
O B 1 d mr (O
i 1 7 ; 6 4T ty (O 4 y c
O B p s o n CGPGWNORG KX G ( 0 CNK SOWWKS KX G
( d c O B s POXG KX G (
uc O B 7GLSO KX G ( ) u
8B d c 8B v i O ks u 9 OK KX
G ( d c mr u H676c1IXO OS 1cm 389A// (
613 s u CW PO GRG GSJ NOSGXG ( ds (O 4c 8B c Ocm 613
u O B i 76 u N; k
-
u t d cs i
2 c u 3 d
c u O B o n kn u
d m u n tyc u
( d e O B x n x c(
d hb ( d mr
O B c 9SSK 3K GWW 93 mr O B
c O B ca mr i
B F( O B cb mr O B k B F( i d x
c O 8B m o (.%) c)-% c
n d c k c u O /
c 8B / /- o u d 8B k /
oc O ) k , o s o
-
n d (O 4 613 - c) /, o t c ( ( c ,(
o d c
(O 4c Oc 8B c613 m z .( ( c-( c, / c m B F(
s o n ds c m O B m
o s u d
c u O B o u m
u s o p n kn u d
,- n ( . cz ) n O B u
)1 dz c ,, ) n x uc .
u d ( n (. ., u oc O B u c(O 4
n ) c613 n , c O n )/ c 8B n i )2 ds t
o oc613 o n )3 d
O B u (O 4cm 613 u O B 76 c O m 8B
u O B N; c,- ucz -
i )2 d c o t n / k .( o
i s n c o t d u k c(O 4
) ) c613 - - c O ( c 8B (
m o )2 d c(O 4c Ocm 8B n
oc613 n o )4 d c613
t O B o CD 5 31 cB 1c3;.c8 6)H t s n cs
t O B m i s o n )5 d
-
P
s p u O B i
r o i 4K TW 1SMK KW KX G ( ocs
l c s l n
on l d n c m O B m
o s o n d c O B u
n un n d s c t O B
u o l s i dz 613 t
O B m u d c
;THG GWNO KX G ( k c O B n o n kn
s o dz c y c
O B c s o l d
-
o k i oc O B
i c o mr
c c oi d
P
Wu J, Platero-Luengo A, Sakurai M, Sugawara A, Gil MA, Yamauchi T, Suzuki K, Bogliotti YS, Cuello C, Morales Valencia M, Okumura D, Luo J, Vilariño M, Parrilla I, Soto DA, Martinez CA, Hishida T, Sánchez-Bautista S, Martinez-Martinez ML, Wang H, Nohalez A, Aizawa E, Martinez-Redondo P, Ocampo A, Reddy P, Roca J, Maga EA, Esteban CR, Berggren WT, Nuñez Delicado E, Lajara J, Guillen I, Guillen P, Campistol JM, Martinez EA, Ross PJ, Izpisua Belmonte JC. Interspecies chimerism with mammalian pluripotent stem cells. Cell 2017, 168(3):473-486.
Wu J, Yamauchi T, Izpisua Belmonte JC. An overview of mammalian pluripotency. Development 2016, 143(10):1644-1648. doi: 10.1242/dev.132928.
S
Kobayashi, T., Yamaguchi, T., Hamanaka, S., Kato-Itoh, M., Yamazaki, Y., Ibata, M., Sato, H., Lee, Y.-S., Usui, J., Knisely, A.S., et al. (2010). Generation of rat pancreas in mouse by interspecific blastocyst injection of pluripotent stem cells. Cell 142, 787–799.
Wu, J., and Izpisua Belmonte, J.C. (2016). Stem cells: a renaissance in human biology research. Cell 165, 1572–1585.
Gafni, O., Weinberger, L., Mansour, A.A., Manor, Y.S., Chomsky, E., Ben-Yo- sef, D., Kalma, Y., Viukov, S., Maza, I., Zviran, A., et al. (2013). Derivation of novel human ground state naive pluripotent stem cells. Nature 504, 282–286.
Takashima, Y., Guo, G., Loos, R., Nichols, J., Ficz, G., Krueger, F., Oxley, D., Santos, F., Clarke, J., Mansfield, W., et al. (2014). Resetting transcription factor control circuitry toward ground-state pluripotency in human. Cell 158, 1254–1269.
Theunissen, T.W., Powell, B.E., Wang, H., Mitalipova, M., Faddah, D.A., Reddy, J., Fan, Z.P., Maetzel, D., Ganz, K., Shi, L., et al. (2014). Systematic identification of culture conditions for induction and maintenance of naive hu- man pluripotency. Cell Stem Cell 15, 471–487.
-
Wu, J., and Izpisua Belmonte, J.C. (2015). Dynamic pluripotent stem cell states and their applications. Cell Stem Cell 17, 509–525.
Okita, K., Matsumura, Y., Sato, Y., Okada, A., Morizane, A., Okamoto, S., Hong, H., Nakagawa, M., Tanabe, K., Tezuka, K., et al. (2011). A more efficient method to generate integration-free human iPS cells. Nat. Methods 8, 409–412.
Irie, N., Weinberger, L., Tang, W.W.C., Kobayashi, T., Viukov, S., Manor, Y.S., Dietmann, S., Hanna, J.H., and Surani, M.A. (2015). SOX17 is a critical specifier of human primordial germ cell fate. Cell 160, 253–268.
Tsukiyama, T., and Ohinata, Y. (2014). A modified EpiSC culture condition con- taining a GSK3 inhibitor can support germline-competent pluripotency in mice. PLoS ONE 9, e95329.
De Los Angeles, A., Ferrari, F., Xi, R., Fujiwara, Y., Benvenisty, N., Deng, H., Hochedlinger, K., Jaenisch, R., Lee, S., Leitch, H.G., et al. (2015). Hallmarks of pluripotency. Nature 525, 469–478.